18th Orphan Drugs & Rare Diseases Global Congress 2022 Americas - East Coast

Addressing Scientific Challenges to Advance New Treatments for Rare Diseases

29th - 30th November 2022 - 2 Days Conference


Hyatt Regency Boston


1 Ave de Lafayette, Boston, MA 02111, United States


+1 617-912-1234

18th Orphan Drugs & Rare Diseases Global Congress 2022 - US Boston

Orphan Drugs & Rare Diseases

Paradigm Global Events is again proud to present our Orphan Drugs and Rare Diseases Global Congress 2022 Americas. It’s the 18th in the series of our Flagship tri-annual Orphan Drugs & Rare Diseases event. This congress will provide you with a comprehensive overview of the critical issues shaping the future of Orphan Drugs.

The COVID-19 Pandemic has impacted the lives of just about everyone, patients receiving continuous treatment and care included. The Rare Disease community is already experiencing considerable challenges in achieving early and detailed diagnosis and having access to care and life-saving treatment, to chronic, highly complex, progressive and severely disabling nature of their diseases, which generate specific care needs. Undoubtedly, during this crisis, the rare diseases community is experiencing unprecedented overall disruption even more….

Previously Featured Key Industry Experts

Rogerio Vivaldi

President and Chief Executive Officer, Sigilon Therapeutics Inc.

Sonal Bhatia

Chief Medical Officer, Rare Disease, Pfizer

Paul Strijbos

Advanced Neurotechnology Innovation Leader Roche

Andrea C. Furia-Helms, M.P.H.

Director, Patient Affairs Staff, Office of Clinical Policy and Programs, Office of the Commissioner, U.S. Food and Drug Administration

From a patient advocacy organization perspective, was a very informative meeting. Learned a lot from presentations and networking that will inform how we can add value to the advocacy-patient-drug developer dialogue.

Dr. Nadine Tutton

Scientific Director, Research, Association for Frontotemporal Degeneration

I was very impressed with the format, the content was interesting and well done. I felt I learned a lot and was glad to be able to attend.

Senior Director

Business Development at Pharm-Olam, LLC



The two-day Congress will provide an interactive, cutting edge and comprehensive discussion and networking format led by key experts with intimate knowledge in the industry. Gain practical strategies and best practices on challenges, innovations, technologies and concepts surrounding orphan drugs and rare diseases.

Orphan Drugs & Rare Diseases 2022 Americas


Gold Sponsor

Gold Sponsor

Gold Sponsor

Gold Sponsor

Associate Sponsor


Scroll to Top